Found: 6
Select item for more details and to access through your institution.
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.934700
- By:
- Publication type:
- Article
How I treat refractory/relapsed diffuse large B‐cell lymphomas with CD19‐directed chimeric antigen receptor T cells.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 3, p. 396, doi. 10.1111/bjh.18724
- By:
- Publication type:
- Article
CAR T cell‐driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 212, doi. 10.1002/ajh.26777
- By:
- Publication type:
- Article
CD123 Is Consistently Expressed on NPM1 -Mutated AML Cells.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 496, doi. 10.3390/cancers13030496
- By:
- Publication type:
- Article
Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 13, p. 7231, doi. 10.3390/ijms25137231
- By:
- Publication type:
- Article
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax.
- Published in:
- EJHaem, 2023, v. 4, n. 2, p. 559, doi. 10.1002/jha2.655
- By:
- Publication type:
- Article